Marchetti S, Gimond C, Roux D, Gothié E, Pouysségur J, Pagès Gilles
Institute of Signaling, Developmental Biology and Cancer Research, Nice, France.
J Cell Physiol. 2004 Jun;199(3):441-50. doi: 10.1002/jcp.10465.
The p42/p44 mitogen activated protein kinase (MAPK) pathway participates in a wide range of cellular programs including proliferation, migration, differentiation, and survival. Specific pharmacological inhibitors, like PD98059 and U0126, are often used to inhibit p42/p44 MAPK signaling. However, these inhibitors are not appropriate to study the function of these kinases in whole organisms. We thus developed an inducible system designed to inhibit p42/p44 MAPK activity through the expression of a phosphatase specific for these two kinases, the MAPK phosphatase 3 (MKP-3). A fibroblast cell line was established in which MKP-3 expression is controlled by tetracycline. Tetracycline-induced MKP-3 resulted in partial de-phosphorylation of p42/p44 MAPKs in serum-stimulated cells. However, we could improve MKP-3 stability and thereby the rate of MAPK de-phosphorylation, when the C-terminal end of MKP-3 was fused to the green fluorescent protein (GFP). Importantly, the fusion of GFP to MKP-3 did not alter the specificity of the phosphatase towards its MAPK substrates. We further show that conditional expression of MKP-3-GFP in this fibroblast cell line results in the inhibition of: (a) the phosphorylation of the p42/p44 MAPK substrates Elk1 and HIF-1alpha, (b) vascular endothelial growth factor (VEGF), cyclin D1, and c-fos gene transcription in response to MAPK pathway activation, and (c) cell proliferation. Finally, the MKP-3-GFP inducible cell line was transformed by Ha-ras and injected into nude mice. Treatment of mice with the tetracycline analog doxycycline resulted in a large delay in tumor emergence and growth as compared to the untreated control group, indicating that MKP-3-GFP activity is maintained in vivo. Altogether, these results show that inducible expression of MKP-3-GFP constitutes a valuable tool to study the role of p42/p44 MAPKs in various cellular responses in both cultured cell and animal models, a tool that may also be used to block unwanted cell growth in pathological conditions.
p42/p44丝裂原活化蛋白激酶(MAPK)通路参与多种细胞程序,包括增殖、迁移、分化和存活。特定的药理学抑制剂,如PD98059和U0126,常被用于抑制p42/p44 MAPK信号传导。然而,这些抑制剂不适用于研究这些激酶在整个生物体中的功能。因此,我们开发了一种诱导系统,旨在通过表达一种对这两种激酶具有特异性的磷酸酶——MAPK磷酸酶3(MKP-3)来抑制p42/p44 MAPK活性。建立了一种成纤维细胞系,其中MKP-3的表达受四环素控制。四环素诱导的MKP-3导致血清刺激细胞中p42/p44 MAPKs的部分去磷酸化。然而,当MKP-3的C末端与绿色荧光蛋白(GFP)融合时,我们可以提高MKP-3的稳定性,从而提高MAPK去磷酸化的速率。重要的是,GFP与MKP-3的融合并没有改变磷酸酶对其MAPK底物的特异性。我们进一步表明,在这种成纤维细胞系中条件性表达MKP-3-GFP会导致以下情况受到抑制:(a)p42/p44 MAPK底物Elk1和HIF-1α的磷酸化;(b)响应MAPK通路激活时血管内皮生长因子(VEGF)、细胞周期蛋白D1和c-fos基因的转录;(c)细胞增殖。最后,用Ha-ras转化MKP-3-GFP诱导细胞系并将其注射到裸鼠体内。与未处理的对照组相比,用四环素类似物强力霉素处理小鼠会导致肿瘤出现和生长的大幅延迟,这表明MKP-3-GFP活性在体内得以维持。总之,这些结果表明,MKP-3-GFP的诱导表达构成了一种有价值的工具,可用于研究p42/p44 MAPKs在培养细胞和动物模型的各种细胞反应中的作用,该工具也可用于在病理条件下阻断不必要的细胞生长。